Low-Molecular-Weight Heparin for Adult ICU Patients Who Require Thromboprophylaxis : Protocol for the INCEPT-Thromboprophylaxis Platform Trial Domain
Background: Low-molecular-weight heparin (LMWH) is recommended for thromboprophylaxis in adult intensive care unit (ICU) patients. Despite its widespread use, there is insufficient evidence on the optimal dose, and there appears to be practice variation. Determining the LMWH dosing strategy that most effectively balances the risks of venous thromboembolism (VTE) and bleeding may improve outcomes i
